Top Analyst Upgrades and Downgrades: Apple, Annaly, Jabil, Lululemon, Xerox, WebMD and More

April 8, 2015 by Jon C. Ogg

Stocks were looking for direction on Wednesday morning after the gains failed to Hold on Tuesday. If one trend has remained constant over the past three years, it is that investor shave lined up in droves to buy their favorite stocks every time the market pulls back. 24/7 Wall St. reviews dozens of analyst research reports each day to find new trading or investment ideas for its readers. Some of analyst calls cover stocks to buy, but other reports are about stocks to sell or avoid.

These are this Wednesday’s top analyst upgrades and downgrades.

Angie’s List Inc. (NASDAQ: ANGI) was downgraded to Neutral from Buy and the price target was slashed to $6.75 from $12.50 (versus a $6.07 close) at B. Riley.

Almost Family Inc. (NASDAQ: AFAM) was downgraded to Neutral from Outperform with a price target of $48 (versus a prior $44 price target and a $47.76 close) at R.W. Baird.

Annaly Capital Management Inc. (NYSE: NLY) was downgraded to Underperform from Market Perform and the price target was cut to $10 from $12 (versus a $10.42 close) at FBR Capital Markets.

Apple Inc. (NASDAQ: AAPL) received its first downgrade in a while. Societe Generale cut Apple to Hold from Buy based on Apple nearing its $130 price target. Another concern is how Apple can replicate the success of its iPhone 6 model when it has another upgrade later this year — and there is a concern that currency headwinds could cap its revenues.

ALSO READ: The 6 Cheapest Stocks From Goldman Sachs

Cinemark Holdings Inc. (NYSE: CNK) was downgraded to Neutral from Buy with a $44 fair value target at Janney Capital Markets.

Cummins Inc. (NYSE: CMI) was downgraded to Neutral from Buy and given a $155 price target (versus a $136.76 close) at Goldman Sachs.

Crestwood Equity Partners L.P. (NYSE: CEQP) was downgraded to Neutral from Buy at Bank of America Merrill Lynch.

Dealertrack Technologies Inc. (NASDAQ: TRAK) was started as Neutral with a $44 price objective at Merrill Lynch.

Energous Corp. (NASDAQ: WATT) was started as Buy with a $15 price target (versus a $8.71 close) at Roth Capital. This is even a higher target than the very bullish call seen from Oppenheimer last month.

Energy Transfer Equity L.P. (NYSE: ETE) was started on the Conviction Buy List with an $86 price target (versus a $63.28 close) at Goldman Sachs.

ALSO READ: 6 RBC Top Tech Stocks to Buy Ahead of Earnings

Health Care REIT Inc. (NYSE: HCN) was started as Outperform and a price target of $86 (versus a $78.12 close) at BMO Capital Markets.

Jabil Circuit Inc. (NYSE: JBL) was raised to Outperform from Market Perform with a $27 price target (versus a $23.25 close) by Raymond James.

Lululemon Athletica Inc. (NASDAQ: LULU) was raised to Buy from Neutral with a $77 price target (versus a $66.41 close) at Sterne Agee.

Qualys Inc. (NASDAQ: QLYS) was raised to Buy from Hold with a price target of $61 (versus a $46 prior target and a $49.08 close) at Topeka Capital Markets.

Regal Entertainment Group (NYSE: RGC) was downgraded to Neutral from Buy at Janney Capital Markets.

Trina Solar Ltd. (NYSE: TSL) was downgraded to Neutral from Buy at Merrill Lynch.

Verastem Inc. (NASDAQ: VSTM) was started as Buy with a price target of $16.00 (versus a $9.92 close) at HC Wainwright.

Visteon Corp. (NYSE: VC) was raised to Overweight from Equal Weight and the price target was raised to $121 from $107 (versus a $98.16 close) at Barclays.

WebMD Health Corp. (NASDAQ: WBMD) was downgraded to Sell from an already cautious Neutral rating at Goldman Sachs.

ALSO READ: Merrill Lynch’s Top Worries Ahead of Earnings Season

Xerox Corp. (NYSE: XRX) was raised to Buy from Neutral with a $15 price target (versus a $12.96 close) at Citigroup. The report talks up the company’s M&A efforts to buy more services revenues, and the weakness in 2015 has created a value proposition.

Yingli Green Energy Holding Co. Ltd. (NYSE: YGE) was downgraded to Underperform from Neutral at Merrill Lynch.

Zendesk Inc. (NYSE: ZEN) was started with a Buy rating and was given a $28 price target (versus a $22.50 close) at Merrill Lynch.

In case you missed Tuesday’s top upgrades and downgrades, they were in shares of American Express, BIND Therapeutics, Devon Energy, General Motors, Novavax, Toyota and over a dozen more companies.